Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran.

Nalini M, Oranuba E, Poustchi H, Sepanlou SG, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Abnet CC, Boffetta P, Brennan P, Sotoudeh M, Nikmanesh A, Merat S, Etemadi A, Shakeri R, Sohrabpour AA, Nasseri-Moghaddam S, Kamangar F, Malekzadeh R.

BMJ Open. 2018 Jul 18;8(7):e021479. doi: 10.1136/bmjopen-2018-021479.

2.

Prevalence of Chronic Constipation and Its Associated Factors in Pars Cohort Study: A Study of 9000 Adults in Southern Iran.

Moezi P, Salehi A, Molavi H, Poustchi H, Gandomkar A, Imanieh MH, Malekzadeh R.

Middle East J Dig Dis. 2018 Apr;10(2):75-83. doi: 10.15171/mejdd.2018.94. Epub 2018 Mar 15.

3.

Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium.

Fahimfar N, Khalili D, Sepanlou SG, Malekzadeh R, Azizi F, Mansournia MA, Roohafza H, Emamian MH, Hadaegh F, Poustchi H, Mansourian M, Hashemi H, Sharafkhah M, Pourshams A, Farzadfar F, Steyerberg EW, Fotouhi A.

BMJ Open. 2018 Jul 5;8(7):e020303. doi: 10.1136/bmjopen-2017-020303.

4.

Nut consumption and the risk of oesophageal squamous cell carcinoma in the Golestan Cohort Study.

Hashemian M, Murphy G, Etemadi A, Poustchi H, Sharafkhah M, Kamangar F, Pourshams A, Malekshah AF, Khoshnia M, Gharavi A, Hekmatdoost A, Brennan PJ, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R.

Br J Cancer. 2018 Jul;119(2):176-181. doi: 10.1038/s41416-018-0148-0. Epub 2018 Jun 28.

PMID:
29950612
5.

The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study.

Khaledifar A, Hashemzadeh M, Solati K, Poustchi H, Bollati V, Ahmadi A, Kheiri S, Samani KG, Banitalebi M, Sedehi M, Malekzadeh R.

BMC Public Health. 2018 May 25;18(1):660. doi: 10.1186/s12889-018-5364-2.

6.

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study.

Nalini M, Sepanlou SG, Pourshams A, Poustchi H, Sharafkhah M, Bahrami H, Kamangar F, Malekzadeh R.

Arch Iran Med. 2018 Mar 1;21(3):86-94.

PMID:
29688733
7.

Significant SNPs Related to Telomere Length and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Carriers

Mohamadkhani A, Pourasgari M, Poustchi H.

Asian Pac J Cancer Prev. 2018 Mar 27;19(3):585-590.

8.

The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform.

Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, Farjam M, Zare Sakhvidi MJ, Miri-Monjar M, Moosazadeh M, Hakimi H, Rahimi Kazerooni S, Cheraghian B, Ahmadi A, Nejatizadeh A, Mohebbi I, Pourfarzi F, Roozafzai F, Motamed-Gorji N, Montazeri SA, Masoudi S, Amin-Esmaeili M, Danaie N, Mirhafez SR, Hashemi H, Poustchi H, Malekzadeh R.

Arch Iran Med. 2017 Nov 1;20(11):691-695.

PMID:
29480734
9.

Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.

Fadaei R, Meshkani R, Poustchi H, Fallah S, Moradi N, Panahi G, Merat S, Golmohammadi T.

Arch Physiol Biochem. 2018 Jan 23:1-6. doi: 10.1080/13813455.2018.1429475. [Epub ahead of print]

PMID:
29359590
10.

Building cancer registries in a lower resource setting: The 10-year experience of Golestan, Northern Iran.

Roshandel G, Semnani S, Fazel A, Honarvar M, Taziki M, Sedaghat S, Abdolahi N, Ashaari M, Poorabbasi M, Hasanpour S, Hosseini S, Mansuri S, Jahangirrad A, Besharat S, Moghaddami A, Mirkarimi H, Salamat F, Ghasemi-Kebria F, Jafari N, Shokoohifar N, Gholami M, Sadjadi A, Poustchi H, Bray F, Malekzadeh R.

Cancer Epidemiol. 2018 Feb;52:128-133. doi: 10.1016/j.canep.2017.12.014. Epub 2018 Jan 4.

PMID:
29306787
11.

Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study.

Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, Mirminachi B, Nasseri-Moghaddam S, Semnani S, Shakeri R, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Kamangar F, Malekzadeh R.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):268-273. doi: 10.1158/1055-9965.EPI-17-0592. Epub 2017 Dec 20.

12.

Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design.

Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, Mohammadi Z, Mahmoudi Z, Shayanrad A, Roozafzai F, Sheikh M, Jalaeikhoo A, Somi MH, Mansour-Ghanaei F, Najafi F, Bahramali E, Mehrparvar A, Ansari-Moghaddam A, Enayati AA, Esmaeili Nadimi A, Rezaianzadeh A, Saki N, Alipour F, Kelishadi R, Rahimi-Movaghar A, Aminisani N, Boffetta P, Malekzadeh R.

Am J Epidemiol. 2018 Apr 1;187(4):647-655. doi: 10.1093/aje/kwx314.

PMID:
29145581
13.

Toenail mineral concentration and risk of esophageal squamous cell carcinoma, results from the Golestan Cohort Study.

Hashemian M, Murphy G, Etemadi A, Poustchi H, Brockman JD, Kamangar F, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Brennan PJ, Boffetta P, Hekmatdoost A, Malekzadeh R, Abnet CC.

Cancer Med. 2017 Dec;6(12):3052-3059. doi: 10.1002/cam4.1247. Epub 2017 Nov 10.

14.

The association between waterpipe smoking and gastroesophageal reflux disease.

Etemadi A, Gandomkar A, Freedman ND, Moghadami M, Fattahi MR, Poustchi H, Islami F, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R.

Int J Epidemiol. 2017 Dec 1;46(6):1968-1977. doi: 10.1093/ije/dyx158.

PMID:
29025018
15.

Prevalence and Correlates of Gastroesophageal Reflux Disease in Southern Iran: Pars Cohort Study.

Khodamoradi Z, Gandomkar A, Poustchi H, Salehi A, Imanieh MH, Etemadi A, Malekzadeh R.

Middle East J Dig Dis. 2017 Jul;9(3):129-138. doi: 10.15171/mejdd.2017.63.

16.

The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population.

Rabiee B, Roozafzai F, Hemasi GR, Poustchi H, Keyvani H, Khonsari MR, Ajdarkosh H, Maadi M, Sima Saeedian F, Zamani F.

Middle East J Dig Dis. 2017 Apr;9(2):86-93. doi: 10.15171/mejdd.2017.56.

17.

Multimorbidity as an important issue among women: results of a gender difference investigation in a large population-based cross-sectional study in West Asia.

Alimohammadian M, Majidi A, Yaseri M, Ahmadi B, Islami F, Derakhshan M, Delavari A, Amani M, Feyz-Sani A, Poustchi H, Pourshams A, Sadjadi AM, Khoshnia M, Qaravi S, Abnet CC, Dawsey S, Brennan P, Kamangar F, Boffetta P, Sadjadi A, Malekzadeh R.

BMJ Open. 2017 May 9;7(5):e013548. doi: 10.1136/bmjopen-2016-013548.

18.

Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study.

Sepanlou SG, Barahimi H, Najafi I, Kamangar F, Poustchi H, Shakeri R, Hakemi MS, Pourshams A, Khoshnia M, Gharravi A, Broumand B, Nobakht-Haghighi A, Kalantar-Zadeh K, Malekzadeh R.

PLoS One. 2017 May 3;12(5):e0176540. doi: 10.1371/journal.pone.0176540. eCollection 2017.

19.

Oral health and mortality in the Golestan Cohort Study.

Vogtmann E, Etemadi A, Kamangar F, Islami F, Roshandel G, Poustchi H, Pourshams A, Khoshnia M, Gharravi A, Brennan PJ, Boffetta P, Dawsey SM, Malekzadeh R, Abnet CC.

Int J Epidemiol. 2017 Dec 1;46(6):2028-2035. doi: 10.1093/ije/dyx056.

PMID:
28449082
20.

Egg consumption and risk of non-alcoholic fatty liver disease.

Mokhtari Z, Poustchi H, Eslamparast T, Hekmatdoost A.

World J Hepatol. 2017 Apr 8;9(10):503-509. doi: 10.4254/wjh.v9.i10.503.

21.

Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.

Naderian M, Kolahdoozan S, Sharifi AS, Garmaroudi G, Yaseri M, Poustchi H, Sohrabpour AA.

Arch Iran Med. 2017 Apr;20(4):211-217. doi: 0172004/AIM.005.

22.

Epidemiologic Study of Opium Use in Pars Cohort Study: A Study of 9000 Adults in a Rural Southern Area of Iran.

Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, Gandomkar A, Malekzadeh R.

Arch Iran Med. 2017 Apr;20(4):205-210. doi: 0172004/AIM.004.

23.

Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes.

Shanaki M, Moradi N, Emamgholipour S, Fadaei R, Poustchi H.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S467-S472. doi: 10.1016/j.dsx.2017.03.037. Epub 2017 Mar 31.

PMID:
28392354
24.

Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality: The Golestan Cohort Study.

Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, Sharafkhah M, Khoshnia M, Farvid M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Pharoah PD, Boffetta P, Willett WC, Malekzadeh R.

Am J Epidemiol. 2017 Apr 15;185(8):697-711. doi: 10.1093/aje/kww139.

25.

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.

Mofidi F, Poustchi H, Yari Z, Nourinayyer B, Merat S, Sharafkhah M, Malekzadeh R, Hekmatdoost A.

Br J Nutr. 2017 Mar;117(5):662-668. doi: 10.1017/S0007114517000204. Epub 2017 Mar 27.

PMID:
28345499
26.

White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran.

Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar F, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G.

BMC Public Health. 2017 Jan 31;17(1):133. doi: 10.1186/s12889-016-3999-4.

27.

The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection.

Afsharzadeh F, Bokharaei-Salim F, Esghaei M, Monavari SH, Merat S, Poustchi H, Haj-Sheykholeslami A, Keyvani H.

Hepat Mon. 2016 Dec 11;16(12):e42388. doi: 10.5812/hepatmon.42388. eCollection 2016 Dec.

28.

Dietary Protein Sources and All-Cause and Cause-Specific Mortality: The Golestan Cohort Study in Iran.

Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, Sharafkhah M, Khoshnia M, Farvid M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Pharoah PD, Boffetta P, Willett WC, Malekzadeh R.

Am J Prev Med. 2017 Feb;52(2):237-248. doi: 10.1016/j.amepre.2016.10.041.

29.

The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients.

Shanaki M, Fadaei R, Moradi N, Emamgholipour S, Poustchi H.

PLoS One. 2016 Dec 9;11(12):e0168082. doi: 10.1371/journal.pone.0168082. eCollection 2016.

30.

Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.

Motamed N, Rabiee B, Perumal D, Poustchi H, Miresmail SJ, Farahani B, Maadi M, Saeedian FS, Ajdarkosh H, Khonsari MR, Hemasi GR, Zamani F.

Int J Cardiol. 2017 Feb 1;228:52-57. doi: 10.1016/j.ijcard.2016.11.048. Epub 2016 Nov 10.

PMID:
27863362
31.

Central Obesity and Liver Iron Content: A Noninvasive Assessment in General Population by Magnetic Resonance Imaging.

Radmard AR, Poustchi H, Hashemi Taheri AP, Gerami Seresht M, Mohammadinejad P, Yoonessi A, Dadgostar M, Rahmanian MS, Jafari E, Zeinoddini A, Malekzadeh R, Merat S.

Ann Nutr Metab. 2016;69(3-4):181-189. doi: 10.1159/000453111. Epub 2016 Nov 18.

PMID:
27855393
32.

The Combined Effects of Healthy Lifestyle Behaviors on All-Cause Mortality: The Golestan Cohort Study.

Fazel-Tabar Malekshah A, Zaroudi M, Etemadi A, Islami F, Sepanlou S, Sharafkhah M, Keshtkar AA, Khademi H, Poustchi H, Hekmatdoost A, Pourshams A, Feiz Sani A, Jafari E, Kamangar F, Dawsey SM, Abnet CC, Pharoah PD, Berennan PJ, Boffetta P, Esmaillzadeh A, Malekzadeh R.

Arch Iran Med. 2016 Nov;19(11):752-761.

33.

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline.

Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, Mohraz M, Mardani M, Fattahi MR, Poustchi H, Nikbin M, Nabavi M, Adibi P, Ziaee M, Behnava B, Rezaee-Zavareh MS, Colombo M, Massoumi H, Bizri AR, Eghtesad B, Amiri M, Namvar A, Hesamizadeh K, Malekzadeh R.

Hepat Mon. 2016 Aug 13;16(8):e40959. eCollection 2016 Aug. Review.

34.

A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study.

Farjam M, Bahrami H, Bahramali E, Jamshidi J, Askari A, Zakeri H, Homayounfar R, Poustchi H, Malekzadeh R.

BMC Public Health. 2016 Oct 18;16(1):1090.

35.

Assessment of Abdominal Fat Distribution in Non-Alcoholic Fatty Liver Disease by Magnetic Resonance Imaging: a Population-based Study.

Radmard AR, Rahmanian MS, Abrishami A, Yoonessi A, Kooraki S, Dadgostar M, Hashemi Taheri AP, Gerami Seresht M, Poustchi H, Jafari E, Malekzadeh R, Merat S.

Arch Iran Med. 2016 Oct;19(10):693-699.

36.

The six obesity indices, which one is more compatible with metabolic syndrome? A population based study.

Motamed N, Sohrabi M, Poustchi H, Maadi M, Malek M, Keyvani H, Amoli MS, Zamani F.

Diabetes Metab Syndr. 2017 Jul - Sep;11(3):173-177. doi: 10.1016/j.dsx.2016.08.024. Epub 2016 Aug 23.

PMID:
27658893
37.

Rural Residency has a Protective Effect and Marriage is a Risk Factor for NAFLD.

Motamed N, Maadi M, Sohrabi M, Keyvani H, Poustchi H, Zamani F.

Hepat Mon. 2016 Jun 19;16(7):e38357. doi: 10.5812/hepatmon.38357. eCollection 2016 Jul.

38.

Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.

Motamed N, Rabiee B, Poustchi H, Dehestani B, Hemasi GR, Khonsari MR, Maadi M, Saeedian FS, Zamani F.

Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):31-38. doi: 10.1016/j.clinre.2016.07.005. Epub 2016 Aug 31.

PMID:
27597641
39.

Reliability Analysis of a Newly Developed Questionnaire for Quality Control of Follow-up Visits in PolyIran Study.

Roshandel G, Ostovaneh MR, Poustchi H, Malekzadeh F, Sepanlou SG, Honarvar MR, Semnani S, Merat S, Malekzadeh R.

Arch Iran Med. 2016 Aug;19(8):551-5. doi: 0161908/AIM.006.

40.

Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease.

Jalili M, Hekmatdoost A, Vahedi H, Poustchi H, Khademi B, Saadi M, Zemestani M, Janani L.

PLoS One. 2016 Aug 4;11(8):e0158545. doi: 10.1371/journal.pone.0158545. eCollection 2016.

41.

Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease.

Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast T, Poustchi H.

Int J Food Sci Nutr. 2016 Dec;67(8):1024-9. doi: 10.1080/09637486.2016.1210101. Epub 2016 Jul 19.

PMID:
27436528
42.

Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer.

Shakeri R, Kamangar F, Mohamadnejad M, Tabrizi R, Zamani F, Mohamadkhani A, Nikfam S, Nikmanesh A, Sotoudeh M, Sotoudehmanesh R, Shahbazkhani B, Ostovaneh MR, Islami F, Poustchi H, Boffetta P, Malekzadeh R, Pourshams A.

Medicine (Baltimore). 2016 Jul;95(28):e3922. doi: 10.1097/MD.0000000000003922.

43.

Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.

Gandomkar A, Poustchi H, Moini M, Moghadami M, Imanieh H, Fattahi MR, Ayatollahi SM, Sagheb MM, Anushiravani A, Mortazavi R, Sepanlou SG, Malekzadeh R.

Int J Public Health. 2017 Apr;62(3):397-406. doi: 10.1007/s00038-016-0848-2. Epub 2016 Jun 28.

PMID:
27349480
44.

Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron.

Moossavi S, Besharat S, Sharafkhah M, Ghanbari R, Sharifi A, Rezanejad P, Pourshams A, Poustchi H, Mohamadkhani A.

Middle East J Dig Dis. 2016 Apr;8(2):122-30. doi: 10.15171/mejdd.2016.17.

45.

The Prevalence of Hepatitis B Virus Among Municipal Solid Waste Workers: Necessity for Immunization of At-Risk Groups.

Ansari-Moghaddam A, Ansari H, Khosravi S, Sanei-Moghaddam E, Mohammadi M, Alavian SM, Poustchi H.

Hepat Mon. 2016 Mar 6;16(3):e30887. doi: 10.5812/hepatmon.30887. eCollection 2016 Mar.

46.

Flaxseed Supplementation in Metabolic Syndrome Management: A Pilot Randomized, Open-labeled, Controlled Study.

Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A.

Phytother Res. 2016 Aug;30(8):1339-44. doi: 10.1002/ptr.5635. Epub 2016 May 6.

PMID:
27151322
47.

Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.

Katoonizadeh A, Sharafkhah M, Ostovaneh MR, Norouzi A, Khoshbakht N, Mohamadkhani A, Eslami L, Gharravi A, Shayanrad A, Khoshnia M, Esmaili S, George J, Poustchi H, Malekzadeh R.

J Viral Hepat. 2016 Oct;23(10):805-11. doi: 10.1111/jvh.12543. Epub 2016 Apr 29.

PMID:
27126365
48.

Effects of Synbiotics Supplementation in Lean Patients with Nonalcoholic Fatty Liver Disease: Study Protocol of a Pilot Randomized Double-blind Clinical Trial.

Mofidi F, Yari Z, Poustchi H, Merat S, Nourinayyer B, Malekzadeh R, Hekmatdoost A.

Arch Iran Med. 2016 Apr;19(4):282-4. doi: 0161904/AIM.000010.

49.

Major Dietary Protein Sources in Relation to Pancreatic Cancer: a Large Prospective Study.

Ghorbani Z, Pourshams A, Fazeltabar Malekshah A, Sharafkhah M, Poustchi H, Hekmatdoost A.

Arch Iran Med. 2016 Apr;19(4):248-56. doi: 0161904/AIM.005.

50.

Abdominal fat distribution and carotid atherosclerosis in a general population: a semi-automated method using magnetic resonance imaging.

Radmard AR, Poustchi H, Ansari L, Khorasanizadeh F, Yoonessi A, Hashemi Taheri AP, Rahmanian MS, Jafari E, Malekzadeh R, Merat S.

Jpn J Radiol. 2016 Jun;34(6):414-22. doi: 10.1007/s11604-016-0540-8. Epub 2016 Mar 25.

PMID:
27015838

Supplemental Content

Loading ...
Support Center